Alnylam Pharmaceuticals | ALNY - 营业费用

股票价格

311.10

每天变化

-3.70 -1.18%

每月一次

-7.46%

每年

22.70%

Q1 预测

303.95

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 40.65B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	营业费用	更改		日
Acadia Pharmaceuticals	USD 266.6M		23.72M	2025-12
Agios Pharmaceuticals	USD 141.54M		11.8M	2025-12
Alnylam Pharmaceuticals	USD 965.32M		84.27M	2025-12
Amgen	USD 5.9B		773M	2025-12
Arrowhead Research	USD 223.22M		10.86M	2025-12
BioCryst Pharmaceuticals	USD 146.17M		534.06M	2025-12
BioMarin Pharmaceutical	USD 676.18M		131.65M	2025-12
Incyte	USD 1.12B		3.53B	2025-12
Ionis Pharmaceuticals	USD 418M		101.1M	2025-12
Moderna	USD 1.54B		259M	2025-12
Neurocrine Biosciences	USD 577.6M		22M	2025-12
Novartis	USD 9.8B		23M	2025-12
PTC Therapeutics	USD 246.3M		38.78M	2025-12
Regeneron Pharmaceuticals	USD 2.99B		27.97B	2025-12
Sangamo BioSciences	USD 33.87M		12.89M	2024-06
Sanofi	EUR 10.71B		1.32B	2025-12
Sarepta Therapeutics	USD 853.02M		390.78M	2025-12
Takeda	JPY 1.02T		400.98B	2025-12
Tectonic Therapeutic	USD 21.52M		374K	2025-12
Ultragenyx Pharmaceutical	USD 321M		9.82M	2025-12
Vertex Pharmaceuticals	USD 1.93B		89.1M	2025-12
Xencor	USD 81.86M		13.35M	2025-12